Yang Zheng
Hebei Medical University(CN)Zhejiang University of Science and Technology(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Hubei University of Chinese Medicine(CN)University of Michigan–Ann Arbor(US)University of Michigan(US)Affiliated Hospital of Southwest Medical University(CN)Zhejiang Province Institute of Architectural Design and Research(CN)Fourth Hospital of Hebei Medical University(CN)Michigan Center for Translational Pathology(US)First Affiliated Hospital of GuangXi Medical University(CN)Guangdong Academy of Medical Sciences(CN)Guangdong Provincial People's Hospital(CN)Zhejiang University of Technology(CN)Southern Medical University(CN)Zhejiang University(CN)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, RNA modifications and cancer, Cancer Immunotherapy and Biomarkers, Peptidase Inhibition and Analysis, interferon and immune responses
Most-Cited Works
- → miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges(2018)669 cited
- → Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapy(2014)151 cited
- → Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors(2013)138 cited
- → Epigenetic silencing of chemokine CCL2 represses macrophage infiltration to potentiate tumor development in small cell lung cancer(2020)83 cited
- → MicroRNA-223-3p modulates dendritic cell function and ameliorates experimental autoimmune myocarditis by targeting the NLRP3 inflammasome(2019)57 cited
- → Machine learning-based analysis identifies and validates serum exosomal proteomic signatures for the diagnosis of colorectal cancer(2024)56 cited